Fiduciary Management Inc. WI reduced its holdings in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 0.7% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 937,951 shares of the technology company's stock after selling 6,806 shares during the quarter. Fiduciary Management Inc. WI owned 3.46% of Plexus worth $120,180,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also modified their holdings of the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its stake in Plexus by 0.6% during the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 975,612 shares of the technology company's stock worth $125,005,000 after acquiring an additional 6,257 shares in the last quarter. American Century Companies Inc. raised its stake in Plexus by 24.7% during the first quarter. American Century Companies Inc. now owns 678,222 shares of the technology company's stock worth $86,901,000 after acquiring an additional 134,205 shares in the last quarter. Nuveen Asset Management LLC raised its stake in Plexus by 6.6% during the fourth quarter. Nuveen Asset Management LLC now owns 351,557 shares of the technology company's stock worth $55,012,000 after acquiring an additional 21,911 shares in the last quarter. Fuller & Thaler Asset Management Inc. raised its stake in Plexus by 120.4% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 348,510 shares of the technology company's stock worth $44,655,000 after acquiring an additional 190,360 shares in the last quarter. Finally, Northern Trust Corp raised its stake in Plexus by 10.0% during the fourth quarter. Northern Trust Corp now owns 332,100 shares of the technology company's stock worth $51,967,000 after acquiring an additional 30,163 shares in the last quarter. 94.45% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts have issued reports on the company. Benchmark reaffirmed a "buy" rating and issued a $160.00 target price on shares of Plexus in a report on Wednesday, June 4th. Stifel Nicolaus set a $140.00 target price on Plexus in a report on Thursday, July 24th. Wall Street Zen cut Plexus from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 16th. Needham & Company LLC lowered their target price on Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a report on Thursday, July 24th. Finally, Sidoti raised Plexus from a "neutral" rating to a "buy" rating and upped their target price for the stock from $135.00 to $150.00 in a report on Friday, July 25th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $152.00.
View Our Latest Stock Report on PLXS
Plexus Trading Up 1.4%
NASDAQ PLXS opened at $130.55 on Friday. The business's 50-day moving average price is $132.30 and its two-hundred day moving average price is $130.17. Plexus Corp. has a 12 month low of $103.43 and a 12 month high of $172.89. The firm has a market capitalization of $3.52 billion, a PE ratio of 22.24 and a beta of 0.80. The company has a current ratio of 1.58, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06.
Plexus (NASDAQ:PLXS - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.19. Plexus had a return on equity of 12.33% and a net margin of 4.04%.The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same quarter in the previous year, the company posted $1.45 EPS. The business's revenue was up 6.0% on a year-over-year basis. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. On average, analysts expect that Plexus Corp. will post 5.9 EPS for the current year.
Insider Transactions at Plexus
In other news, COO Oliver K. Mihm sold 2,102 shares of the business's stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $130.43, for a total value of $274,163.86. Following the transaction, the chief operating officer directly owned 21,155 shares of the company's stock, valued at $2,759,246.65. The trade was a 9.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Todd P. Kelsey sold 1,500 shares of the business's stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $125.63, for a total value of $188,445.00. Following the completion of the transaction, the chief executive officer directly owned 72,214 shares in the company, valued at $9,072,244.82. This represents a 2.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 12,484 shares of company stock worth $1,626,335. 1.76% of the stock is currently owned by insiders.
Plexus Company Profile
(
Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.